| 00:00:26 |
Obey, David R. - U.S. Representative, [D] Wisconsin
BRIEFING ON THE H1N1 PANDEMIC. FRANKLY, THIS COMMITTEE, IN MY VIEW, HAS HAD BOTH A POSITIVE AND NEGATIVE EFFECT ON THE ISSUE OF PREPARING THE NATION...
|
| 00:09:27 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
SO IT'S -- THE REASON WE ARE WHERE WE ARE -- I MEAN, WE COULD POINT A LOT OF FINGERS IN A LOT OF DIRECTIONS. I THINK WHAT WE OUGHT TO -- SINCE WE'RE...
|
| 00:11:38 |
Lewis, Jerry - U.S. Representative, [R] California
WE COULD PROCEED WITH THIS BRIEFING, AND WITH A LITTLE RANCOR ALONG PARTISAN POLITICS AS POSSIBLE. SO THANK YOU. >> LET ME SIMPLY SAY THAT THIS BRIEFING...
|
| 00:12:08 |
Obey, David R. - U.S. Representative, [D] Wisconsin
FRANK LOOK AT ANY THINGS THAT NEED TO CHANGE IN THE FUTURE IN ORDER TO STRENGTHEN OUR CAPACITY TO DEAL WITH THIS IN THE FUTURE. AND WITH THAT, LET ME...
|
| 00:14:24 |
Frieden, Thomas - Director
DEATH. OUR MENTARIAN TO ADDRESS THIS ENEMY, AS YOU SAID, MR. CHAIRMAN, IS OUT OF DATE, AND REQUIRES UPDATING. I'M PLEASED TO HAVE BEEN ASKED TO WORK...
|
| 00:21:25 |
Lurie, Nicole - Assistant Secretary
THE FRUSTRATIONS, WE BEGAN REBUILDING THE VACCINE INFRASTRUCTURE IN THIS COUNTRY SEVERAL YEARS AGO. AND AS A RESULT, WHEN WE DECIDED TO PURSUE VACCINE...
|
| 00:27:02 |
Obey, David R. - U.S. Representative, [D] Wisconsin
AGENCIES IN ADDRESSING THE VERY
|
| 00:27:05 |
Fauci, Anthony S. M.D. - Director
DAUNTING PROBLEM OF THIS EXTRAORDINARY PANDEMIC. AS I HAVE TESTIFIED BEFORE THIS COMMITTEE SO MANY TIMES IN THE PAST, THAT THE MANDATE OF THE NIH...
|
| 00:34:42 |
Obey, David R. - U.S. Representative, [D] Wisconsin
REPEATEDLY FOR HIS PUBLIC HEALTH EXPERTISE AND FOR HIS
|
| 00:34:46 |
Bonner, Josiah "Jo" - U.S. Representative, [R] Alabama
EFFORTS ON BEHALF OF ALABAMA'S CHILDREN AS WELL AS OUR 4.5 MILLION OTHER CITIZENS AND IS ONE OF THE LEADING VOICES ON PUBLIC HEALTH, AND I KNOW TODAY...
|
| 00:36:24 |
Obey, David R. - U.S. Representative, [D] Wisconsin
DEALT ARE ACROSS THE NATION. IN MY
|
| 00:36:26 |
Williamson, Donald - Officer
COMMENTS I'LL FOCUS ON A FEW CRITICAL COMPONENTS OF THAT RESPONSE. SURVEILLANCE, MEDICAL CARE CAPACITY, AND VACCINE ADMINISTRATION. SCHOOL BEGAN IN...
|
| 00:42:27 |
Obey, David R. - U.S. Representative, [D] Wisconsin
DEPARTMENT OF PUBLIC HEALTH SINCE 1988, AND THE LABOR HEALTH
|
| 00:42:32 |
McCollum, Betty - U.S. Representative, [D] Minnesota
AND HUMAN SERVICES EDUCATION MEMBER, HE'S HERE TO BRIEF US ON H1N1. ROB DIRECTS AN OPERATION OF LARGE, FULL-SERVICE PUBLIC HEALTH ENTITY FOCUSING...
|
| 00:44:11 |
Fulton, Rob - Director
FOR TB, STDs, FAMILY PLANNING, WOMEN'S HEALTH AS WELL AS A MOMENT VISITING PROGRAM SERVING OVER 1900 FAMILIES A YEAR. WE HAVE 320 STAFF AND A BUDGET...
|
| 00:51:39 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
THE VACCINE. PERHAPS SOMEONE WILL EXPLAIN THE TIMELINE FOR US? >> WE'LL GET TO THAT, BUT I WANT TO PROVIDE AN OPPORTUNITY FOR BOTH MINORITY AND MAJORITY...
|
| 00:52:05 |
Obey, David R. - U.S. Representative, [D] Wisconsin
MINUTES. >> GOOD MORNING. I WANT TO FIRST TALK ABOUT THE H1N1 VACCINE SHORTAGES THAT DR. WILLIAMSON AND MR. FULTON OUTLINED FOR PROBLEMS IN THE STATE...
|
| 00:52:29 |
Kunko, Nicole - Staff Assistant
MANUFACTURING CAPACITY TO PRODUCE VACCINE FOR THE ENTIRE U.S. POPULATION OF 300 MILLION PERSONS WITHIN SIX MONTHS OF PANDEMIC ONSET. WHILE HHS PARTICULARLY...
|
| 00:54:11 |
Frieden, Thomas - Director
FOCUSED ON GOING REALLY WEEK TO WEEK IN TERMS OF WHAT WE'RE ANTICIPATING COMING TO US. WHAT WE FOCUSED ON AT CDC IS ENSURING WE CAN RECEIVE THE VACCINE...
|
| 00:54:57 |
Kunko, Nicole - Staff Assistant
WE'RE VERY CONFIDENT IN THE SAFETY OF BUT TAKE TOO LONG. IN THE INITIAL ESTIMATES WERE SIX TO NINE MONTHS AFTER A VACCINE BECOMES -- A VACCINATION BECOMING...
|
| 00:55:07 |
Frieden, Thomas - Director
EMERGENCE OF A NEW STRAIN. IF YOU LOOK AT THE PREVIOUS PANDEMICS AND VACCINE PRODUCTION, IT HAS BEEN REALLY NOT POSSIBLE TO HAVE VACCINE AVAILABLE...
|
| 00:56:00 |
Kunko, Nicole - Staff Assistant
BY PROJECTIONS THAT HAVE NOT COME TO PASS. AND OUR GOAL NOW IS TO GET THE VACCINE OUT AS RAPIDLY AS
|
| 00:56:10 |
Frieden, Thomas - Director
POSSIBLE AND THEN TO ENSURE THAT ONCE IT'S AVAILABLE IT'S USED BY THE PRIORITY POPULATIONS TO THE GREATEST EXTENT PASSABLE. >> IF I CAN INTERRUPT,...
|
| 00:56:40 |
Obey, David R. - U.S. Representative, [D] Wisconsin
WHAT THE FUTURE TIMELINES WOULD BE. >> WELL, MAYBE I CAN JUMP IN HERE, IF I CAN. WE HAVE BEEN WORKING EXTREMELY HARD WITH EACH OF THE MANUFACTURERS TO...
|
| 00:57:04 |
Lurie, Nicole - Assistant Secretary
THE PROBLEMS THAT THEY ENCOUNTERED EARLY ON IN TERMS OF GROWTH, IN TERMS OF FILLING LINE CAPACITY, ET CETERA, SEEM TO HAVE BEEN VERY WELL ADDRESSED....
|
| 00:58:15 |
Kunko, Nicole - Staff Assistant
A GRAPHIC WHICH SHORT OF MIGHT HELP A LITTLE BIT TO EXPLAIN THINGS. BUT AT THIS POINT, YOU KNOW, THE MANUFACTURERS
|
| 00:58:25 |
Lurie, Nicole - Assistant Secretary
REALLY ARE WHERE THEY ARE WITH THEIR PRODUCTION -- THAT'S NOT GOING TO BE VERY EASY TO SEE. MAYBE WE COULD JUST PASS THIS OUT TO THE COMMITTEE. LET'S...
|
| 01:01:12 |
Kunko, Nicole - Staff Assistant
TO REALLY HAVE A BALANCE BETWEEN BEING SURE WE'VE GOT ENOUGH VACCINE THROUGHOUT THE TIME THAT PEOPLE NEED AND WANT IT, AND BEING CAREFUL STEWARDS OF...
|
| 01:01:32 |
Lurie, Nicole - Assistant Secretary
WHAT'S CALLED FILL AND FINISH, TO PUT IT IN VIALS, TO CENTER RIL STERILITY TEST IT AND THOSE ISSUES. WE'VE DONE THAT FOR THE FIRST 117 MILLION TO BE...
|
| 01:03:14 |
Kunko, Nicole - Staff Assistant
TAKE AS LONG TO PRODUCE A SEED STRAIN, IT HAS THE ADDED BENEFIT OF THE VACCINE TO BE PROVIDED TO PEOPLE WITH EGG ALLERGIES, MADE FOUR WEEKS FASTER AND...
|
| 01:04:21 |
Lurie, Nicole - Assistant Secretary
THE FIRST CELL-BASED MANUFACTURING FACILITY IS NOW BEING BUILT IN HOLLY SPRINGS, NORTH CAROLINA, BY NOVARTIS AND WE'VE PROVIDED SUBSTANTIAL FUNDSING...
|
| 01:05:32 |
Kunko, Nicole - Staff Assistant
THAT. I WANT TO POINT OUT THAT AS YOU'VE ALLUDED TO AND AS YOUR MEMBERS HAVE ALLUDED
|
| 01:05:39 |
Lurie, Nicole - Assistant Secretary
TO, WE NEED THIS MANUFACTURING CAPACITY IN THE UNITED STATES. THIS CELL-BASED FACILITY IS THE FIRST ONE. IT'S GOING TO GET US MAYBE A LITTLE SHY...
|
| 01:06:41 |
Fauci, Anthony S. M.D. - Director
THE CELLS. SO WHEN YOU HAVE TO GET THE VIRUS TO GROW, THERE'S NO GUARANTEE THAT YOU'RE GOING TO ALL OF A SUDDEN GET AWAY FROM ALL OF THE VIE SIS TUDS...
|
| 01:08:35 |
Kunko, Nicole - Staff Assistant
I'M ABLE TO ANSWER WHETHER THEY WILL BE MORE EXPENSIVE. CERTAINLY THERE'S INVESTMENT AND RESEARCH DEVELOPMENT THAT GOES INTO MAKING AND PRODUCING ANY...
|
| 01:08:51 |
Lurie, Nicole - Assistant Secretary
SCALE. BUT I DON'T THINK I COULD PREDICT THAT NOW. >> IN GENERAL, NEW TECHNOLOGIES WHEN THEY START OFF TURN OUT TO BE MORE EXPENSIVE, THE MOW ELECTRIC...
|
| 01:09:15 |
Fauci, Anthony S. M.D. - Director
GOT A TECHNOLOGY, THAT TECHNOLOGY CAN YOU GUARANTEE IS GOING TO BE MORE EXPENSIVE INITIALLY AND ULTIMATELY BECOMES MUCH LESS EXPENSIVE. >> HAD HHS INVESTED...
|
| 01:09:46 |
Kunko, Nicole - Staff Assistant
THAT I DON'T HAVE THE HINDSIGHT TO BE ABLE TO ANSWER THAT QUESTION. YOU KNOW, THINGS ALWAYS TAKE LONGER THAN THEY SHOULD HAVE. I CAN REMEMBER WE...
|
| 01:10:04 |
Lurie, Nicole - Assistant Secretary
AND WE STARTED INVESTING VERY HEAVILY IN THE SCIENCE AT THAT POINT. LARGELY UNDER DR. FAUCI'S LEADERSHIP TO MOVE TO CELL-BASED AND SOME OF THE NEWER...
|
| 01:10:57 |
Obey, David R. - U.S. Representative, [D] Wisconsin
HOW MUCH IS AVAILABLE SO WE CAN GET SOME PROJECTIONS AND I THINK THAT MIGHT BE HELPFUL. >> WHY DON'T EITHER YOU OR YOUR STAFF TAKE TEN MINUTES. >>...
|
| 01:11:11 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
COMING DOWN FROM THE SKY AND I COULDN'T CONNECT THAT WITH WHAT'S GOING ON. DO WE HAVE TO AIR DROP THIS IN OR -- >> I WISH WE COULD. >> THAT'S DOROTHY...
|
| 01:11:22 |
Obey, David R. - U.S. Representative, [D] Wisconsin
KANSAS. >> KICK YOUR HEELS AND WE'LL GET HER
|
| 01:11:25 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
HOME. >> THEY'RE
|
| 01:11:26 |
Lurie, Nicole - Assistant Secretary
|
| 01:11:27 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
ORANGE, BUT NOT QUITE LIKE THE RED SHOES I HAVE ON. SO WHAT THAT'S REALLY INTENDED TO CONVEY IS WE'RE STILL DEPENDENT ON GROWING VACCINE IN EGG. ...
|
| 01:11:38 |
Lurie, Nicole - Assistant Secretary
THAT'S A PALLET OF EGGS. WHAT THIS IS INTENDED TO SHOW IS THAT
|
| 01:11:42 |
Obey, David R. - U.S. Representative, [D] Wisconsin
UNTIL WE HAVE THESE NEW TECHNOLOGIES,
|
| 01:11:44 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
WE'VE HAD TO INVEST IN MAINTAINING A STEADY
|
| 01:11:47 |
Lurie, Nicole - Assistant Secretary
SUPPLY OF MILLIONS AND MILLIONS OF EGGS. >> IT SAYS WE'VE STARTED THE EGG SUPPLY CONTRACT IN 2004. >> RIGHT. >> SO HOW MANY EGGS DO YOU NEED -- IS
|
| 01:11:57 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
IT ONE VACCINE PER EGG OR
|
| 01:11:59 |
Lurie, Nicole - Assistant Secretary
IS IT MULTIPLE EGGS THAT ARE REQUIRED? >> SO ONE OF THE CHALLENGES AS I THINK DURING SEASONAL FLU VACCINE AND MY COLLEAGUES CAN CORRECT ME IF I'M...
|
| 01:12:12 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
SOMETIMES THREE DOSES
|
| 01:12:14 |
Lurie, Nicole - Assistant Secretary
OF VACCINE
|
| 01:12:15 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
PER EGG. BUT EACH VIRUS GROWS AT A DIFFERENT RATE. FOR THIS H1N1, I THINK WHEN PEOPLE STARTED WITH A VERY FIRST STRAINS,
|
| 01:12:24 |
Lurie, Nicole - Assistant Secretary
THEY WERE GETTING ABOUT .2, .3 DOSES PER EGG, AND THEY'VE DONE A LOT OF WORK. >> SO THEY'VE BEEN ABLE TO INCREASE THE CAPACITY. >> TO INCREASE THAT...
|
| 01:12:51 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
ABSOLUTELY. >> WELL, SO IF YOU WERE
|
| 01:12:54 |
Lurie, Nicole - Assistant Secretary
GOING TO LOOK AT A TIMELINE AND YOU
|
| 01:12:56 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
NEED TO INCREASE THE DOSAGE, YOU START WITH, WHAT? YOU START
|
| 01:13:00 |
Lurie, Nicole - Assistant Secretary
WITH ORDERING EGGS OR BUYING CHICKENS OR HOW DO YOU START? >> SO WHAT HAVE YOU TO DO ON THE TIMELINE IS DO A COUPLE THINGS SIMULTANEOUSLY. YOU HAVE...
|
| 01:13:14 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
NATED EGGS. >> IT TAKES A WHILE TO ORDER THEM. >> WE HAVE A STEADY SUPPLY AND A STEADY ORDER NOW, SO THAT'S NOT THE HANGUP AND THAT'S BECAUSE OF...
|
| 01:13:24 |
Lurie, Nicole - Assistant Secretary
OKAY? BUT THEN WHEN A NEW STRAIN COMES ALONG, WHAT HAVE YOU TO DO IS ISOLATE THE VIRUS, GET THE SEED STRAIN AS DR. FAUCI ALLUDED TO IN HIS GRAPHIC,...
|
| 01:13:35 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
TO GROW SO THAT YOU CAN ACTUALLY -- >> HOW LONG DOES IT
|
| 01:13:38 |
Lurie, Nicole - Assistant Secretary
TAKE TO ISOLATE THE VIRUS? IS THERE AN AVERAGE TIME OR IS THERE A UNIQUE TIME? >> JUST DAYS IN FACT. THIS VIRUS WAS ISOLATED IN CALIFORNIA BY CDC WORK...
|
| 01:13:58 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
CONSTANTLY LOOKING FOR A MUTATED STRAIN. >> WITHIN THE RESEARCH WE HAVE, YES. >> SO HOW DO THEY GROW ENOUGH TO PUT INTO THE EGGS, HOW LONG DOES THAT...
|
| 01:14:07 |
Frieden, Thomas - Director
STEP IS THAT CDC WILL ISOLATE THE VIRUS, SELECT A CANDIDATE STRAIN THAT LOOKS LIKE IT WILL BE GOOD FOR VACCINE, AND SEND THAT TO
|
| 01:14:18 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
PARTNER INSTITUTIONS THAT WILL THEN CHANGE IT TO A FORM THAT
|
| 01:14:22 |
Frieden, Thomas - Director
IS FACILITATES THE MAKING OF VACCINE
|
| 01:14:24 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
T TOOK US LITERALLY DAYS TO GET THAT DONE AFTER ISOLATING THE
|
| 01:14:28 |
Frieden, Thomas - Director
VIRUS. WE PROVIDED IT TO PARTNERS, THE PARTNERS THEN PROVIDE IT OPENLY TO MANUFACTURERS, ACADEMIC INSTITUTIONS, GOVERNMENTS AROUND THE COUNTRY AND...
|
| 01:15:02 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
DO THAT. YOU HAVE VIRUS THAT'S ARE VERY GOOD GROWERS AND ADAPTED TO EGGS, PUERTO RICAN STRAIN -- >> WHAT'S THE
|
| 01:15:10 |
Lurie, Nicole - Assistant Secretary
LONGEST IT WOULD TAKE, THEN? >> IT COULD TAKE SEVERAL WEEKS, IT COULD TAKE A MONTH IF YOU
|
| 01:15:14 |
Fauci, Anthony S. M.D. - Director
DON'T GET A GOOD STRAIN OFF A SEED VIRUS. IF YOU DO IT REAL QUICK AND YOU'RE LUCKY, DAYS TO A COUPLE OF WEEKS, IF IT TAKES A LONG TIME, YOU COULD...
|
| 01:15:30 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
TO GET READY TO INOCULATE THE EGGS. >>
|
| 01:15:32 |
Fauci, Anthony S. M.D. - Director
RIGHT. >> AND HOW LONG FOR IT TO INCUBATE WITHIN THE EGGS? >> THAT TAKES MONTHS AND MONTHS. THAT DEPENDS ON HOW QUICKLY IT GROWS. SO IF YOU HAVE...
|
| 01:15:47 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
REFERENCE STRAIN OR THE SEED VIRUS, YOU GROW IT UP, YOU GIVE IT TO THE DIFFERENT COMPANIES AND THEY
|
| 01:15:52 |
Fauci, Anthony S. M.D. - Director
START ADAPTING IT
|
| 01:15:53 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
TO THEIR EGG SYSTEM OR WHATEVER SYSTEM THEY USE, IF IT HITS THE GROUND
|
| 01:15:57 |
Fauci, Anthony S. M.D. - Director
RUNNING AND IT'S REALLY A GOOD GROWER, YOU COULD START MAKING THAT RIGHT AWAY AND GETTING YIELDS WITHIN A PERIOD OF A CUPOUPLE OF MONTHS. THE WHOLE...
|
| 01:16:30 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
SEEMS KIND OF NEBULOUS NOW. I CAN'T PROJECT FORWARD THAT IF I NEEDED 100,000 VACCINES AT SOME POINT IN TIME, WHEN WOULD I EXPECT THOSE TO BE AVAILABLE?...
|
| 01:16:40 |
Fauci, Anthony S. M.D. - Director
YOU ORDER A
|
| 01:16:41 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
PRODUCT, IT HAS A DELIVER DATE. WHALTZ THE DELIVER DATE FOR 100,000 VIALS? >> PLANNING ALWAYS SAID SIX TO NINE MONTHS. >> BUT 100,000, MR. TIAHRT,...
|
| 01:17:12 |
Frieden, Thomas - Director
FEW DAYS IF YOU HAVE A BIG ENOUGHN'T PLA. BUT ON A REGULAR FLU YEAR WHERE
|
| 01:17:18 |
Fauci, Anthony S. M.D. - Director
YOU HAVE A REASONABLY
|
| 01:17:20 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
GOOD GROWER, NO GLITCHES, FROM THE
|
| 01:17:22 |
Fauci, Anthony S. M.D. - Director
TIME YOU ISOLATE THE VIRUS OR MAKE THE DECISION OF WHAT'S YOU'RE GOING TO
|
| 01:17:25 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
PUT IN YOUR VACCINE TO THE TIME YOU GET IT IN THE VIAL RANGES FROM SIX
|
| 01:17:29 |
Fauci, Anthony S. M.D. - Director
TO NINE MONTHS. SIX TO EIGHT MONTHS. >> AND WE CAN EXPECT THE SAME FOR THE H1N1? >> WE HAD HOPED THAT THAT'S WITH A THE CASE AND THERE WERE A COUPLE...
|
| 01:17:52 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
VACCINE, YOU USUALLY MAKE YOUR DECISION AROUND JANUARY AND
|
| 01:17:55 |
Fauci, Anthony S. M.D. - Director
YOU START THIS PROCESS. YOU USUALLY, IF IT'S A REASONABLY GOOD GROWER, YOU GET WHAT YOU NEED AROUND THE MIDDLE OF THE SUMMER, YOU START GETTING IT...
|
| 01:19:34 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
OF
|
| 01:19:36 |
Obey, David R. - U.S. Representative, [D] Wisconsin
SLUSHY. THEN I'M NOT SURE WE CAN
|
| 01:19:38 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
PROPERLY MANAGE IT, BECAUSE CAN YOU SAY, IT'S GOING TO TAKE LONGER THAN WE EXPECTED, THAT'S JUST THE WAY IT IS. I WANT TO MAKE SURE WE'RE MANAGING...
|
| 01:20:23 |
Fauci, Anthony S. M.D. - Director
IS, AND WE SWALLOW HARD WHEN WE SAY IT, YOU REALLY CAN'T DO ANYTHING WHEN YOU HAVE A VIRUS THAT'S NOT GROWING WELL EXCEPT TO WIGGLE IT AROUND TO GET...
|
| 01:21:12 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
FOR AUSTRALIA, NOT A SURPRISE, SO WE HAVE LIMITED CAPACITY HERE AND THIS SLUSH IN THE SCHEDULE. DOES THAT APPLY TO WORLDWIDE OR IS IT WORSE OVERSEAS,...
|
| 01:21:49 |
Fauci, Anthony S. M.D. - Director
THIMEROSAL-FREE TOOK
|
| 01:21:52 |
Obey, David R. - U.S. Representative, [D] Wisconsin
CONSIDERABLY
|
| 01:21:53 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
LONGER
|
| 01:21:54 |
Obey, David R. - U.S. Representative, [D] Wisconsin
THAN IT DID TO PRODUCE THE SAME COMPOUND, IF YOU HAD THIMEROSAL. HAS THAT CONTROVERSY, IN YOUR JUDGMENT, ADDED APPRECIABLY TO THE TIME THAT IT'S TAKEN...
|
| 01:22:37 |
Fauci, Anthony S. M.D. - Director
YOU MULTI DOSE VIALS THAT WOULD REQUIRE HAVING A PRPRESERVE TIVE LIKE THIMEROSAL IN IT, IT
|
| 01:22:43 |
Obey, David R. - U.S. Representative, [D] Wisconsin
FACILITATES THE PROCESS, RATHER THAN HAVING TO PUT SINGLE -- BUT I DON'T THINK THAT'S THE ANSWER TO THE PROBLEM. THE ANSWER TO THE PROBLEM IS THE FUNDAMENTAL,...
|
| 01:22:57 |
Fauci, Anthony S. M.D. - Director
MOREIMEROSAL IS ADDED TO THE END OF THOSE VIALS AS A PRESERVE TIVE. SO IF THE PROBLEM IS WHETHER THE VIRUS GROWS AND WHETHER YOU GET TO THOSE BIG VATS...
|
| 01:23:20 |
Lurie, Nicole - Assistant Secretary
THAT'S A GREAT QUESTION. >> THAT'S A GREAT QUESTION. >> THERE'S A DIFFERENCE BETWEEN HOW IT GROWS IN THE LABORATORY AND HOW IT SPREADS FROM PERSON TO...
|
| 01:23:35 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
VIRUS CIRCULATING WIDELY IN DECADES, AND THAT MEANS THAT IT CAN SPREAD RAPIDLY
|
| 01:23:41 |
Frieden, Thomas - Director
AMONG PEOPLE WHO DON'T
|
| 01:23:42 |
Lurie, Nicole - Assistant Secretary
HAVE ANY
|
| 01:23:43 |
Frieden, Thomas - Director
IMMUNEITY HAVE HAVING BEEN EXPOSED TO SIMILAR VIRUSES IN THE PAST. >> SO IT'S THE STRAIN THAT'S UNUSUAL TO OUR YOUNGER POPULATION NOW THAT ALLOWS...
|
| 01:24:07 |
Tiahrt, Todd - U.S. Representative, [R] Kansas
VACCINATION. ONE IS HEALTH CARE WORKERS WHO CARE FOR PEOPLE WITH INFLUENZA, AND NEED TO BE PROTECTED. THE SECOND IS PREGNANT WOMEN WHO ARE AT HIGHER...
|
| 01:24:26 |
Frieden, Thomas - Director
IS KIDS AND YOUNG ADULTS FROM 6 MONTHS TO 24 YEARS OF AGE WHO ARE MORE LIKELY TO GET THE ILLNESS AND THEN THE FIFTH IS PEOPLE 25 TO 64 WHO HAVE UNDERLYING...
|
| 01:25:07 |
Obey, David R. - U.S. Representative, [D] Wisconsin
VOTE. >> THANK YOU, MR. CHAIRMAN, FOR HAVING THIS IMPORTANT HEARING. I WANT TO GO BACK TO THE SHORTAGE ISSUE. THERE HAVE BEEN NEWS MEDIA REPORTS OF...
|
| 01:25:32 |
Roybal-Allard, Lucille - U.S. Representative, [D] California
AND IN LOS ANGELES COUNTY, FOR EXAMPLE, ABOUT 5.5 MILLION PEOPLE FALL INTO THE PRIORITY CATEGORIES FOR GETTING VACCINATED, BUT ONLY ABOUT 50,000 PEOPLE...
|
| 01:26:44 |
Frieden, Thomas - Director
VACCINATED. OUR GOAL HAS ALWAYS BEEN VACCINE SHOULD BE AVAILABLE TO EVERYONE WHO WANTS TO BE VACCINATED, STARTING WITH THE PRIORITY GROUPS. UNDERSTANDING...
|
| 01:28:17 |
Roybal-Allard, Lucille - U.S. Representative, [D] California
BILLION TO STATES AND LOCALITIES FOR PLANNING AND ADMINISTRATION OF VACCINE. SOME STATES ARE WORKING THROUGH MANAGED CARE ORGANIZATIONS, SOME THROUGH...
|
| 01:28:29 |
Frieden, Thomas - Director
OFFICES, MANY ARE DOING SCHOOL LOCATED VACCINE CLINICS, AND WE HAVE SOME EXCELLENT EXAMPLES OF EACH OF THESE THINGS WORKING VERY WELL. BUT WE'VE LEFT...
|
| 01:29:07 |
Williamson, Donald - Officer
CHILDREN IN KINDERGARTEN THROUGH 12th GRADE AND DO WHAT SCHOOL BASED VACCINATION CLINICS. IT HAS BEEN PUSHED FURTHER INTO THE FUTURE. TO REACH PREGNANT...
|
| 01:30:50 |
Obey, David R. - U.S. Representative, [D] Wisconsin
THE FILLING AND FINISHING TOOK CONSIDERABLY LONGER WITH THE MERITS OF FREE VACCINE. LET ME CALL ON THE CLERK TO EXPAND ON THAT. I AM STILL -- WHETHER...
|
| 01:31:34 |
Fauci, Anthony S. M.D. - Director
FILL-FINNISH ISSUE. THE ISSUE WE ARE FACING IS MUCH LESS A DELAY IN AND FILL-FINISHED THEN IT IS IN A DELAY IN HOW IT BROS. OBVIOUSLY, YOU MAY BE ABLE...
|
| 01:32:16 |
Obey, David R. - U.S. Representative, [D] Wisconsin
THE COMPANIES. QUICKLY TO DO EVERYTHING YOU CAN TO MAXIMIZE
|
| 01:32:20 |
Lurie, Nicole - Assistant Secretary
THE NUMBER OF DOSES THAT GET OUT THERE QUICKLY. REGARDLESS OF WHETHER THAT IS A MULTIVOTE DOSE -- WE ASK THE COMPANIES TO DIFFERENTIAL THE FELL AS...
|
| 01:33:17 |
Obey, David R. - U.S. Representative, [D] Wisconsin
LAST THURSDAY, HOUSE DEMOCRATS INTRODUCED THE HEALTH CARE BILL. THIS WEEK, THE BILL COMES TO THE HOUSE FLOOR. FOLLOW THE ENTIRE DEBATE LIVE WITHOUT...
|
NOTE: The transcript for this program was compiled from uncorrected Closed Captioning.